Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Johnson

Showing results (101-110 of 163) with videos related to

Pageof 17
Sort By:
Acta Biomaterialia|July 29, 2021
Tendinopathy and tendon material response to load: What we can learn from small animal studiesPatrick M Williamson, Benjamin R Freedman, Nicholas Kwok, et al.
The Journal of Trauma and Acute Care Surgery|March 11, 2023
Lower incidence of blunt cerebrovascular injury among young, properly restrained children: An ATOMAC multicenter studyTodd A Nickoles, Ruth A Lewit, David M Notrica, et al.
Diabetes, Obesity & Metabolism|December 22, 2017
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trialRichard E Pratley, Roy Eldor, Annaswamy Raji, et al.
The Journal of Trauma and Acute Care Surgery|January 24, 2023
Diagnostic accuracy of screening tools for pediatric blunt cerebrovascular injury: An ATOMAC multicenter studyTodd A Nickoles, Ruth A Lewit, David M Notrica, et al.
Cells|June 2, 2021
PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine TumorsZeta Chow, Jeremy Johnson, Aman Chauhan, et al.
Diabetes, Obesity & Metabolism|September 19, 2017
Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized studySamuel Dagogo-Jack, Jie Liu, Roy Eldor, et al.
Cancer Letters|May 27, 2024
Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumorZeta Chow, Jeremy Johnson, Aman Chauhan, et al.
Protein Science : a Publication of the Protein Society|April 29, 2021
Transition metal cation inhibition of Mycobacterium tuberculosis esterase RV0045CIsobel E Bowles, Emily H Pool, Benjamin S Lancaster, et al.
The Journal of Trauma and Acute Care Surgery|June 13, 2025
The A+ criteria for pediatric blunt cerebrovascular injury: An ATOMAC+ multicenter studyTodd A Nickoles, James W Eubanks, Ruth A Lewit, et al.
Brain Research|May 2, 2006
Characterization of Gpr101 expression and G-protein coupling selectivityBrian Bates, Lynn Zhang, Stan Nawoschik, et al.
Pageof 17

Showing results (101-110 of 163) with videos related to

Sort By:
Pageof 17
Acta Biomaterialia|July 29, 2021
Tendinopathy and tendon material response to load: What we can learn from small animal studiesPatrick M Williamson, Benjamin R Freedman, Nicholas Kwok, et al.
The Journal of Trauma and Acute Care Surgery|March 11, 2023
Lower incidence of blunt cerebrovascular injury among young, properly restrained children: An ATOMAC multicenter studyTodd A Nickoles, Ruth A Lewit, David M Notrica, et al.
Diabetes, Obesity & Metabolism|December 22, 2017
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trialRichard E Pratley, Roy Eldor, Annaswamy Raji, et al.
The Journal of Trauma and Acute Care Surgery|January 24, 2023
Diagnostic accuracy of screening tools for pediatric blunt cerebrovascular injury: An ATOMAC multicenter studyTodd A Nickoles, Ruth A Lewit, David M Notrica, et al.
Cells|June 2, 2021
PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine TumorsZeta Chow, Jeremy Johnson, Aman Chauhan, et al.
Diabetes, Obesity & Metabolism|September 19, 2017
Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized studySamuel Dagogo-Jack, Jie Liu, Roy Eldor, et al.
Cancer Letters|May 27, 2024
Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumorZeta Chow, Jeremy Johnson, Aman Chauhan, et al.
Protein Science : a Publication of the Protein Society|April 29, 2021
Transition metal cation inhibition of Mycobacterium tuberculosis esterase RV0045CIsobel E Bowles, Emily H Pool, Benjamin S Lancaster, et al.
The Journal of Trauma and Acute Care Surgery|June 13, 2025
The A+ criteria for pediatric blunt cerebrovascular injury: An ATOMAC+ multicenter studyTodd A Nickoles, James W Eubanks, Ruth A Lewit, et al.
Brain Research|May 2, 2006
Characterization of Gpr101 expression and G-protein coupling selectivityBrian Bates, Lynn Zhang, Stan Nawoschik, et al.
Pageof 17